These results suggest FSTL3 be an important player in the complex gene regulatory mechanisms triggering CRC through the processes such as promoting the binding of FN1 to α5β1, activating the EMT phenotype, and M2 macrophage infiltration, ultimately promoting tumor progression. Here, FN1 is linked to colorectal carcinoma.